{"transactions":[{"id":2629058,"issuer":{"id":15490,"kind":"organization","name":"Imago BioSciences, Inc.","symbol":"IMGO"},"owners":[{"id":37276,"kind":"person","name":"Heron Patrick J","position":1,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":2,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":3,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":4,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":5,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2021-07-20T21:54:29.000Z","date":"2021-07-20","kind":"exercise","acquired":false,"shares":225850,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of the Issuer's Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering on July 20, 2021 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of the Issuer's Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering on July 20, 2021 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of the Issuer's Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering on July 20, 2021 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Frazier Healthcare VII, L.P. (\"FH VII\"). The general partner of FH VII is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VII. The Reporting Person is one of six members of FHM VII, L.L.C. The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. each disclaim Section 16 beneficial ownership of the securities held by FH VII, except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":225850},"source":{"system":"sec-edgar","filing":"0001567619-21-013730","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1365617/000156761921013730/doc1.xml","form_type":"4"}},{"id":2629057,"issuer":{"id":15490,"kind":"organization","name":"Imago BioSciences, Inc.","symbol":"IMGO"},"owners":[{"id":37276,"kind":"person","name":"Heron Patrick J","position":1,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":2,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":3,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":4,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":5,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-07-20T21:54:29.000Z","date":"2021-07-20","kind":"exercise","acquired":false,"shares":740673,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of the Issuer's Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering on July 20, 2021 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of the Issuer's Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering on July 20, 2021 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of the Issuer's Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering on July 20, 2021 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Frazier Healthcare VII, L.P. (\"FH VII\"). The general partner of FH VII is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VII. The Reporting Person is one of six members of FHM VII, L.L.C. The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. each disclaim Section 16 beneficial ownership of the securities held by FH VII, except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":740673},"source":{"system":"sec-edgar","filing":"0001567619-21-013730","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1365617/000156761921013730/doc1.xml","form_type":"4"}},{"id":2629056,"issuer":{"id":15490,"kind":"organization","name":"Imago BioSciences, Inc.","symbol":"IMGO"},"owners":[{"id":37276,"kind":"person","name":"Heron Patrick J","position":1,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":2,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":3,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":4,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":5,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A  Preferred Stock","published_at":"2021-07-20T21:54:29.000Z","date":"2021-07-20","kind":"exercise","acquired":false,"shares":1199890,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of the Issuer's Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering on July 20, 2021 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of the Issuer's Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering on July 20, 2021 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of the Issuer's Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering on July 20, 2021 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Frazier Healthcare VII, L.P. (\"FH VII\"). The general partner of FH VII is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VII. The Reporting Person is one of six members of FHM VII, L.L.C. The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. each disclaim Section 16 beneficial ownership of the securities held by FH VII, except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1199890},"source":{"system":"sec-edgar","filing":"0001567619-21-013730","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1365617/000156761921013730/doc1.xml","form_type":"4"}},{"id":2629055,"issuer":{"id":15490,"kind":"organization","name":"Imago BioSciences, Inc.","symbol":"IMGO"},"owners":[{"id":37276,"kind":"person","name":"Heron Patrick J","position":1,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":2,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":3,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":4,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":5,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2021-07-20T21:54:29.000Z","date":"2021-07-20","kind":"exercise","acquired":false,"shares":64360,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of the Issuer's Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering on July 20, 2021 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of the Issuer's Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering on July 20, 2021 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of the Issuer's Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering on July 20, 2021 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held directly by Frazier Healthcare VII-A, L.P. (\"FH VIIA\"). The general partner of FH VIIA is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VIIA. The Reporting Person is one of six members of FHM VII, L.L.C. The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. each disclaim Section 16 beneficial ownership of the securities held by FH VIIA, except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":64360},"source":{"system":"sec-edgar","filing":"0001567619-21-013730","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1365617/000156761921013730/doc1.xml","form_type":"4"}},{"id":2629054,"issuer":{"id":15490,"kind":"organization","name":"Imago BioSciences, Inc.","symbol":"IMGO"},"owners":[{"id":37276,"kind":"person","name":"Heron Patrick J","position":1,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":2,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":3,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":4,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":5,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-07-20T21:54:29.000Z","date":"2021-07-20","kind":"exercise","acquired":false,"shares":211069,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of the Issuer's Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering on July 20, 2021 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of the Issuer's Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering on July 20, 2021 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of the Issuer's Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering on July 20, 2021 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held directly by Frazier Healthcare VII-A, L.P. (\"FH VIIA\"). The general partner of FH VIIA is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VIIA. The Reporting Person is one of six members of FHM VII, L.L.C. The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. each disclaim Section 16 beneficial ownership of the securities held by FH VIIA, except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":211069},"source":{"system":"sec-edgar","filing":"0001567619-21-013730","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1365617/000156761921013730/doc1.xml","form_type":"4"}},{"id":2629053,"issuer":{"id":15490,"kind":"organization","name":"Imago BioSciences, Inc.","symbol":"IMGO"},"owners":[{"id":37276,"kind":"person","name":"Heron Patrick J","position":1,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":2,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":3,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":4,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":5,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A  Preferred Stock","published_at":"2021-07-20T21:54:29.000Z","date":"2021-07-20","kind":"exercise","acquired":false,"shares":341932,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of the Issuer's Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering on July 20, 2021 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of the Issuer's Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering on July 20, 2021 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of the Issuer's Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering on July 20, 2021 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held directly by Frazier Healthcare VII-A, L.P. (\"FH VIIA\"). The general partner of FH VIIA is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VIIA. The Reporting Person is one of six members of FHM VII, L.L.C. The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. each disclaim Section 16 beneficial ownership of the securities held by FH VIIA, except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":341932},"source":{"system":"sec-edgar","filing":"0001567619-21-013730","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1365617/000156761921013730/doc1.xml","form_type":"4"}},{"id":2629052,"issuer":{"id":15490,"kind":"organization","name":"Imago BioSciences, Inc.","symbol":"IMGO"},"owners":[{"id":37276,"kind":"person","name":"Heron Patrick J","position":1,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":2,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":3,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":4,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":5,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-20T21:54:29.000Z","date":"2021-07-20","kind":"exercise","acquired":true,"shares":225850,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of the Issuer's Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering on July 20, 2021 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Frazier Healthcare VII, L.P. (\"FH VII\"). The general partner of FH VII is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VII. The Reporting Person is one of six members of FHM VII, L.L.C. The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. each disclaim Section 16 beneficial ownership of the securities held by FH VII, except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":2312331,"source":{"system":"sec-edgar","filing":"0001567619-21-013730","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1365617/000156761921013730/doc1.xml","form_type":"4"}},{"id":2629051,"issuer":{"id":15490,"kind":"organization","name":"Imago BioSciences, Inc.","symbol":"IMGO"},"owners":[{"id":37276,"kind":"person","name":"Heron Patrick J","position":1,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":2,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":3,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":4,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":5,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-20T21:54:29.000Z","date":"2021-07-20","kind":"exercise","acquired":true,"shares":740673,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of the Issuer's Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering on July 20, 2021 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Frazier Healthcare VII, L.P. (\"FH VII\"). The general partner of FH VII is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VII. The Reporting Person is one of six members of FHM VII, L.L.C. The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. each disclaim Section 16 beneficial ownership of the securities held by FH VII, except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":2086481,"source":{"system":"sec-edgar","filing":"0001567619-21-013730","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1365617/000156761921013730/doc1.xml","form_type":"4"}},{"id":2629050,"issuer":{"id":15490,"kind":"organization","name":"Imago BioSciences, Inc.","symbol":"IMGO"},"owners":[{"id":37276,"kind":"person","name":"Heron Patrick J","position":1,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":2,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":3,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":4,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":5,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-20T21:54:29.000Z","date":"2021-07-20","kind":"exercise","acquired":true,"shares":1199890,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of the Issuer's Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering on July 20, 2021 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Frazier Healthcare VII, L.P. (\"FH VII\"). The general partner of FH VII is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VII. The Reporting Person is one of six members of FHM VII, L.L.C. The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. each disclaim Section 16 beneficial ownership of the securities held by FH VII, except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":1345808,"source":{"system":"sec-edgar","filing":"0001567619-21-013730","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1365617/000156761921013730/doc1.xml","form_type":"4"}},{"id":2629049,"issuer":{"id":15490,"kind":"organization","name":"Imago BioSciences, Inc.","symbol":"IMGO"},"owners":[{"id":37276,"kind":"person","name":"Heron Patrick J","position":1,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":2,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":3,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":4,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":5,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-20T21:54:29.000Z","date":"2021-07-20","kind":"exercise","acquired":true,"shares":64360,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of the Issuer's Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering on July 20, 2021 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held directly by Frazier Healthcare VII-A, L.P. (\"FH VIIA\"). The general partner of FH VIIA is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VIIA. The Reporting Person is one of six members of FHM VII, L.L.C. The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. each disclaim Section 16 beneficial ownership of the securities held by FH VIIA, except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":658943,"source":{"system":"sec-edgar","filing":"0001567619-21-013730","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1365617/000156761921013730/doc1.xml","form_type":"4"}},{"id":2629048,"issuer":{"id":15490,"kind":"organization","name":"Imago BioSciences, Inc.","symbol":"IMGO"},"owners":[{"id":37276,"kind":"person","name":"Heron Patrick J","position":1,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":2,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":3,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":4,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":5,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-20T21:54:29.000Z","date":"2021-07-20","kind":"exercise","acquired":true,"shares":211069,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of the Issuer's Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering on July 20, 2021 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held directly by Frazier Healthcare VII-A, L.P. (\"FH VIIA\"). The general partner of FH VIIA is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VIIA. The Reporting Person is one of six members of FHM VII, L.L.C. The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. each disclaim Section 16 beneficial ownership of the securities held by FH VIIA, except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":594583,"source":{"system":"sec-edgar","filing":"0001567619-21-013730","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1365617/000156761921013730/doc1.xml","form_type":"4"}},{"id":2629047,"issuer":{"id":15490,"kind":"organization","name":"Imago BioSciences, Inc.","symbol":"IMGO"},"owners":[{"id":37276,"kind":"person","name":"Heron Patrick J","position":1,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":2,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":3,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":4,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":5,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-20T21:54:29.000Z","date":"2021-07-20","kind":"exercise","acquired":true,"shares":341932,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of the Issuer's Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering on July 20, 2021 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held directly by Frazier Healthcare VII-A, L.P. (\"FH VIIA\"). The general partner of FH VIIA is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VIIA. The Reporting Person is one of six members of FHM VII, L.L.C. The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. each disclaim Section 16 beneficial ownership of the securities held by FH VIIA, except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":383514,"source":{"system":"sec-edgar","filing":"0001567619-21-013730","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1365617/000156761921013730/doc1.xml","form_type":"4"}},{"id":2629046,"issuer":{"id":15490,"kind":"organization","name":"Imago BioSciences, Inc.","symbol":"IMGO"},"owners":[{"id":37276,"kind":"person","name":"Heron Patrick J","position":1,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":2,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":3,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":4,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":5,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-20T21:54:29.000Z","date":"2021-07-20","kind":"purchase","acquired":true,"shares":145918,"price":16,"value":2334688.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Frazier Healthcare VII, L.P. (\"FH VII\"). The general partner of FH VII is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VII. The Reporting Person is one of six members of FHM VII, L.L.C. The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. each disclaim Section 16 beneficial ownership of the securities held by FH VII, except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":145918,"source":{"system":"sec-edgar","filing":"0001567619-21-013730","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1365617/000156761921013730/doc1.xml","form_type":"4"}},{"id":2629045,"issuer":{"id":15490,"kind":"organization","name":"Imago BioSciences, Inc.","symbol":"IMGO"},"owners":[{"id":37276,"kind":"person","name":"Heron Patrick J","position":1,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":2,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":3,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":4,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":5,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-20T21:54:29.000Z","date":"2021-07-20","kind":"purchase","acquired":true,"shares":41582,"price":16,"value":665312.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held directly by Frazier Healthcare VII-A, L.P. (\"FH VIIA\"). The general partner of FH VIIA is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VIIA. The Reporting Person is one of six members of FHM VII, L.L.C. The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. each disclaim Section 16 beneficial ownership of the securities held by FH VIIA, except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":41582,"source":{"system":"sec-edgar","filing":"0001567619-21-013730","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365617/000156761921013730/doc1.xml","form_type":"4"}},{"id":3303794,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":1,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":2,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":3,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":4,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"6.500% Exchangeable Senior Subordinated Note due 2025","published_at":"2020-01-23T17:34:03.000Z","date":"2020-01-21","kind":"grant","acquired":true,"shares":333000,"price":333000,"value":110889000000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On January 21, 2020, Iterum Therapeutics Bermuda Limited (the \"Issuer\"), a wholly-owned subsidiary of Iterum Therapeutics plc (the \"Company\"), issued and sold, among other things, 6.500% exchangeable senior subordinated notes due 2025 (the \"Exchangeable Notes\") pursuant to a securities purchase agreement among the Issuer, the Company, the Company's wholly-owned subsidiaries and a group of accredited investors. Subject to the terms of the indenture governing the Exchangeable Notes, on or after January 21, 2021 until the second scheduled trading day immediately preceding January 15, 2025, holders may exchange the Exchangeable Notes at any time. The Exchangeable Notes are exchangeable into, at the Company's election, Ordinary Shares of the Company, cash or a combination of Ordinary Shares and cash, at an initial exchange rate of 1,000 shares per $1,000 principal amount of Exchangeable Notes (equivalent to an initial exchange price of approximately $1.00 per Ordinary Share)."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Exchangeable Notes mature on January 31, 2025, unless earlier exchanged, redeemed or repurchased in accordance with their terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Exchangeable Notes mature on January 31, 2025, unless earlier exchanged, redeemed or repurchased in accordance with their terms."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The Exchangeable Note is held directly by Frazier Healthcare VII-A, L.P. (\"FH VIIA\"). The sole general partner of FH VIIA is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C. FHM VII, L.P. and FHM VII, L.L.C. disclaim Section 16 beneficial ownership of the securities held by FH VIIA, except to the extent of its pecuniary interest therein, if any."}],"balance_after":333000,"derivative":{"expiration_date":"2025-01-31","underlying":"Ordinary Shares","underlying_shares":333000},"source":{"system":"sec-edgar","filing":"0001012975-20-000050","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553071/000101297520000050/edgar.xml","form_type":"4"}},{"id":3303793,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":1,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":2,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":3,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":4,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"6.500% Exchangeable Senior Subordinated Note due 2025","published_at":"2020-01-23T17:34:03.000Z","date":"2020-01-21","kind":"grant","acquired":true,"shares":1167000,"price":1167000,"value":1361889000000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On January 21, 2020, Iterum Therapeutics Bermuda Limited (the \"Issuer\"), a wholly-owned subsidiary of Iterum Therapeutics plc (the \"Company\"), issued and sold, among other things, 6.500% exchangeable senior subordinated notes due 2025 (the \"Exchangeable Notes\") pursuant to a securities purchase agreement among the Issuer, the Company, the Company's wholly-owned subsidiaries and a group of accredited investors. Subject to the terms of the indenture governing the Exchangeable Notes, on or after January 21, 2021 until the second scheduled trading day immediately preceding January 15, 2025, holders may exchange the Exchangeable Notes at any time. The Exchangeable Notes are exchangeable into, at the Company's election, Ordinary Shares of the Company, cash or a combination of Ordinary Shares and cash, at an initial exchange rate of 1,000 shares per $1,000 principal amount of Exchangeable Notes (equivalent to an initial exchange price of approximately $1.00 per Ordinary Share)."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Exchangeable Notes mature on January 31, 2025, unless earlier exchanged, redeemed or repurchased in accordance with their terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Exchangeable Notes mature on January 31, 2025, unless earlier exchanged, redeemed or repurchased in accordance with their terms."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The Exchangeable Note is held directly by Frazier Healthcare VII, L.P. (\"FH VII\"). The sole general partner of FH VII is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the securities held by FH VII. FHM VII, L.P. and FHM VII, L.L.C. disclaim Section 16 beneficial ownership of the securities held by FH VII, except to the extent of its pecuniary interest therein, if any."}],"balance_after":1167000,"derivative":{"expiration_date":"2025-01-31","underlying":"Ordinary Shares","underlying_shares":1167000},"source":{"system":"sec-edgar","filing":"0001012975-20-000050","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553071/000101297520000050/edgar.xml","form_type":"4"}},{"id":3913843,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":37276,"kind":"person","name":"Heron Patrick J","position":1,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":2,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":3,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":4,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":5,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-2 Preferred Shares","published_at":"2018-05-30T21:15:40.000Z","date":"2018-05-30","kind":"exercise","acquired":false,"shares":44940,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Frazier Healthcare VII-A, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Series B-2 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Series B-2 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Not applicable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares are held directly by Frazier Healthcare VII-A, L.P. (\"FH VIIA\"). The sole general partner of FH VIIA is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VIIA. The Reporting Person is one of six members of FHM VII, L.L.C. The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. disclaims Section 16 beneficial ownership of the securities held by FH VIIA, except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":44940},"source":{"system":"sec-edgar","filing":"0001209191-18-034197","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1365617/000120919118034197/doc4.xml","form_type":"4"}},{"id":3913842,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":37276,"kind":"person","name":"Heron Patrick J","position":1,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":2,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":3,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":4,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":5,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-1 Preferred Shares","published_at":"2018-05-30T21:15:40.000Z","date":"2018-05-30","kind":"exercise","acquired":false,"shares":53899,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Frazier Healthcare VII-A, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series B-1 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series B-1 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Not applicable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares are held directly by Frazier Healthcare VII-A, L.P. (\"FH VIIA\"). The sole general partner of FH VIIA is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VIIA. The Reporting Person is one of six members of FHM VII, L.L.C. The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. disclaims Section 16 beneficial ownership of the securities held by FH VIIA, except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":53899},"source":{"system":"sec-edgar","filing":"0001209191-18-034197","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1365617/000120919118034197/doc4.xml","form_type":"4"}},{"id":3913841,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":37276,"kind":"person","name":"Heron Patrick J","position":1,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":2,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":3,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":4,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":5,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Shares","published_at":"2018-05-30T21:15:40.000Z","date":"2018-05-30","kind":"exercise","acquired":false,"shares":141166,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Frazier Healthcare VII-A, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Not applicable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares are held directly by Frazier Healthcare VII-A, L.P. (\"FH VIIA\"). The sole general partner of FH VIIA is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VIIA. The Reporting Person is one of six members of FHM VII, L.L.C. The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. disclaims Section 16 beneficial ownership of the securities held by FH VIIA, except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":141166},"source":{"system":"sec-edgar","filing":"0001209191-18-034197","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1365617/000120919118034197/doc4.xml","form_type":"4"}},{"id":3913840,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":37276,"kind":"person","name":"Heron Patrick J","position":1,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":2,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":3,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":4,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":5,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-2 Preferred Shares","published_at":"2018-05-30T21:15:40.000Z","date":"2018-05-30","kind":"exercise","acquired":false,"shares":157701,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Frazier Healthcare VII, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Series B-2 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Series B-2 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Not applicable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Frazier Healthcare VII, L.P. (\"FH VII\"). The sole general partner of FH VII is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VII. The Reporting Person is one of six members of FHM VII, L.L.C.  The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. disclaims Section 16 beneficial ownership of the securities held by FH VII, except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":157701},"source":{"system":"sec-edgar","filing":"0001209191-18-034197","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1365617/000120919118034197/doc4.xml","form_type":"4"}},{"id":3913839,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":37276,"kind":"person","name":"Heron Patrick J","position":1,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":2,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":3,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":4,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":5,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-1 Preferred Shares","published_at":"2018-05-30T21:15:40.000Z","date":"2018-05-30","kind":"exercise","acquired":false,"shares":189141,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Frazier Healthcare VII, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series B-1 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series B-1 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Not applicable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Frazier Healthcare VII, L.P. (\"FH VII\"). The sole general partner of FH VII is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VII. The Reporting Person is one of six members of FHM VII, L.L.C.  The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. disclaims Section 16 beneficial ownership of the securities held by FH VII, except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":189141},"source":{"system":"sec-edgar","filing":"0001209191-18-034197","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1365617/000120919118034197/doc4.xml","form_type":"4"}},{"id":3913838,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":37276,"kind":"person","name":"Heron Patrick J","position":1,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":2,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":3,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":4,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":5,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Shares","published_at":"2018-05-30T21:15:40.000Z","date":"2018-05-30","kind":"exercise","acquired":false,"shares":495370,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Frazier Healthcare VII, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Not applicable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Frazier Healthcare VII, L.P. (\"FH VII\"). The sole general partner of FH VII is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VII. The Reporting Person is one of six members of FHM VII, L.L.C.  The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. disclaims Section 16 beneficial ownership of the securities held by FH VII, except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":495370},"source":{"system":"sec-edgar","filing":"0001209191-18-034197","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1365617/000120919118034197/doc4.xml","form_type":"4"}},{"id":3913837,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":37276,"kind":"person","name":"Heron Patrick J","position":1,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":2,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":3,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":4,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":5,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2018-05-30T21:15:40.000Z","date":"2018-05-30","kind":"purchase","acquired":true,"shares":101150,"price":13,"value":1314950.0,"ownership":{"direct":false,"nature":"By Frazier Healthcare VII-A, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares are held directly by Frazier Healthcare VII-A, L.P. (\"FH VIIA\"). The sole general partner of FH VIIA is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VIIA. The Reporting Person is one of six members of FHM VII, L.L.C. The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. disclaims Section 16 beneficial ownership of the securities held by FH VIIA, except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":341155,"source":{"system":"sec-edgar","filing":"0001209191-18-034197","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1365617/000120919118034197/doc4.xml","form_type":"4"}},{"id":3913836,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":37276,"kind":"person","name":"Heron Patrick J","position":1,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":2,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":3,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":4,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":5,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2018-05-30T21:15:40.000Z","date":"2018-05-30","kind":"exercise","acquired":true,"shares":44940,"ownership":{"direct":false,"nature":"By Frazier Healthcare VII-A, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Series B-2 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares are held directly by Frazier Healthcare VII-A, L.P. (\"FH VIIA\"). The sole general partner of FH VIIA is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VIIA. The Reporting Person is one of six members of FHM VII, L.L.C. The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. disclaims Section 16 beneficial ownership of the securities held by FH VIIA, except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":240005,"source":{"system":"sec-edgar","filing":"0001209191-18-034197","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1365617/000120919118034197/doc4.xml","form_type":"4"}},{"id":3913835,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":37276,"kind":"person","name":"Heron Patrick J","position":1,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":2,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":3,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":4,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":5,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2018-05-30T21:15:40.000Z","date":"2018-05-30","kind":"exercise","acquired":true,"shares":53899,"ownership":{"direct":false,"nature":"By Frazier Healthcare VII-A, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series B-1 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares are held directly by Frazier Healthcare VII-A, L.P. (\"FH VIIA\"). The sole general partner of FH VIIA is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VIIA. The Reporting Person is one of six members of FHM VII, L.L.C. The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. disclaims Section 16 beneficial ownership of the securities held by FH VIIA, except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":195065,"source":{"system":"sec-edgar","filing":"0001209191-18-034197","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1365617/000120919118034197/doc4.xml","form_type":"4"}},{"id":3913834,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":37276,"kind":"person","name":"Heron Patrick J","position":1,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":2,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":3,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":4,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":5,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2018-05-30T21:15:40.000Z","date":"2018-05-30","kind":"exercise","acquired":true,"shares":141166,"ownership":{"direct":false,"nature":"By Frazier Healthcare VII-A, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares are held directly by Frazier Healthcare VII-A, L.P. (\"FH VIIA\"). The sole general partner of FH VIIA is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VIIA. The Reporting Person is one of six members of FHM VII, L.L.C. The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. disclaims Section 16 beneficial ownership of the securities held by FH VIIA, except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":141166,"source":{"system":"sec-edgar","filing":"0001209191-18-034197","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1365617/000120919118034197/doc4.xml","form_type":"4"}},{"id":3913833,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":37276,"kind":"person","name":"Heron Patrick J","position":1,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":2,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":3,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":4,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":5,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2018-05-30T21:15:40.000Z","date":"2018-05-30","kind":"purchase","acquired":true,"shares":354949,"price":13,"value":4614337.0,"ownership":{"direct":false,"nature":"By Frazier Healthcare VII, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Frazier Healthcare VII, L.P. (\"FH VII\"). The sole general partner of FH VII is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VII. The Reporting Person is one of six members of FHM VII, L.L.C.  The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. disclaims Section 16 beneficial ownership of the securities held by FH VII, except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":1197161,"source":{"system":"sec-edgar","filing":"0001209191-18-034197","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1365617/000120919118034197/doc4.xml","form_type":"4"}},{"id":3913832,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":37276,"kind":"person","name":"Heron Patrick J","position":1,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":2,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":3,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":4,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":5,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2018-05-30T21:15:40.000Z","date":"2018-05-30","kind":"exercise","acquired":true,"shares":157701,"ownership":{"direct":false,"nature":"By Frazier Healthcare VII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Series B-2 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Frazier Healthcare VII, L.P. (\"FH VII\"). The sole general partner of FH VII is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VII. The Reporting Person is one of six members of FHM VII, L.L.C.  The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. disclaims Section 16 beneficial ownership of the securities held by FH VII, except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":842212,"source":{"system":"sec-edgar","filing":"0001209191-18-034197","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1365617/000120919118034197/doc4.xml","form_type":"4"}},{"id":3913831,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":37276,"kind":"person","name":"Heron Patrick J","position":1,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":2,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":3,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":4,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":5,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2018-05-30T21:15:40.000Z","date":"2018-05-30","kind":"exercise","acquired":true,"shares":189141,"ownership":{"direct":false,"nature":"By Frazier Healthcare VII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series B-1 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Frazier Healthcare VII, L.P. (\"FH VII\"). The sole general partner of FH VII is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VII. The Reporting Person is one of six members of FHM VII, L.L.C.  The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. disclaims Section 16 beneficial ownership of the securities held by FH VII, except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":684511,"source":{"system":"sec-edgar","filing":"0001209191-18-034197","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1365617/000120919118034197/doc4.xml","form_type":"4"}},{"id":3913830,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":37276,"kind":"person","name":"Heron Patrick J","position":1,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":2,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":3,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":4,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":5,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2018-05-30T21:15:40.000Z","date":"2018-05-30","kind":"exercise","acquired":true,"shares":495370,"ownership":{"direct":false,"nature":"By Frazier Healthcare VII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Frazier Healthcare VII, L.P. (\"FH VII\"). The sole general partner of FH VII is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VII. The Reporting Person is one of six members of FHM VII, L.L.C.  The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. disclaims Section 16 beneficial ownership of the securities held by FH VII, except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":495370,"source":{"system":"sec-edgar","filing":"0001209191-18-034197","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365617/000120919118034197/doc4.xml","form_type":"4"}},{"id":3933479,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":1,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":2,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":3,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":4,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166688,"kind":"person","name":"FRAZIER ALAN D","position":5,"cik":"0001018534","reported_name":"FRAZIER ALAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166689,"kind":"person","name":"Naini Nader J","position":6,"cik":"0001344203","reported_name":"Naini Nader J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166690,"kind":"person","name":"Every Nathan R","position":7,"cik":"0001531105","reported_name":"Every Nathan R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37276,"kind":"person","name":"Heron Patrick J","position":8,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-05-15T18:25:58.000Z","date":"2018-05-11","kind":"other","acquired":false,"shares":1372000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective May 11, 2018, Frazier Healthcare V, L.P., distributed in-kind, without consideration, a total of 1,372,000 shares of Common Stock of the Issuer to its general and limited partners.  The remaining securities are held by Frazier Healthcare V, L.P.  Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Effective May 11, 2018, Frazier Healthcare V, L.P., distributed in-kind, without consideration, a total of 1,372,000 shares of Common Stock of the Issuer to its general and limited partners.  The remaining securities are held by Frazier Healthcare V, L.P.  Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any."}],"balance_after":973612,"source":{"system":"sec-edgar","filing":"0001012975-18-000437","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1018534/000101297518000437/edgar.xml","form_type":"4"}},{"id":4466745,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":1,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":2,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":3,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":4,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166688,"kind":"person","name":"FRAZIER ALAN D","position":5,"cik":"0001018534","reported_name":"FRAZIER ALAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166689,"kind":"person","name":"Naini Nader J","position":6,"cik":"0001344203","reported_name":"Naini Nader J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166690,"kind":"person","name":"Every Nathan R","position":7,"cik":"0001531105","reported_name":"Every Nathan R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37276,"kind":"person","name":"Heron Patrick J","position":8,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2017-02-06T17:14:58.000Z","date":"2017-02-02","kind":"other","acquired":false,"shares":117235,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This warrant is exercisable at any time."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners.  Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"exercise_price":4.55,"expiration_date":"2018-11-04","underlying":"Common Stock","underlying_shares":117235},"source":{"system":"sec-edgar","filing":"0001012975-17-000092","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1018534/000101297517000092/edgar.xml","form_type":"4"}},{"id":4466744,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":1,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":2,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":3,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":4,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166688,"kind":"person","name":"FRAZIER ALAN D","position":5,"cik":"0001018534","reported_name":"FRAZIER ALAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166689,"kind":"person","name":"Naini Nader J","position":6,"cik":"0001344203","reported_name":"Naini Nader J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166690,"kind":"person","name":"Every Nathan R","position":7,"cik":"0001531105","reported_name":"Every Nathan R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37276,"kind":"person","name":"Heron Patrick J","position":8,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-02-06T17:14:58.000Z","date":"2017-02-02","kind":"other","acquired":true,"shares":117235,"price":4.55,"value":533419.25,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners.  Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any."}],"balance_after":2345612,"source":{"system":"sec-edgar","filing":"0001012975-17-000092","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1018534/000101297517000092/edgar.xml","form_type":"4"}},{"id":4475845,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":1,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":2,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":3,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":4,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166688,"kind":"person","name":"FRAZIER ALAN D","position":5,"cik":"0001018534","reported_name":"FRAZIER ALAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166689,"kind":"person","name":"Naini Nader J","position":6,"cik":"0001344203","reported_name":"Naini Nader J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166690,"kind":"person","name":"Every Nathan R","position":7,"cik":"0001531105","reported_name":"Every Nathan R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37276,"kind":"person","name":"Heron Patrick J","position":8,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred Stock","published_at":"2017-01-31T16:20:33.000Z","date":"2017-01-31","kind":"exercise","acquired":false,"shares":209095,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations.  The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations.  The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations.  The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F7","text":"Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners.  Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners.  Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":209095},"source":{"system":"sec-edgar","filing":"0001012975-17-000071","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1018534/000101297517000071/edgar.xml","form_type":"4"}},{"id":4475844,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":1,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":2,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":3,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":4,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166688,"kind":"person","name":"FRAZIER ALAN D","position":5,"cik":"0001018534","reported_name":"FRAZIER ALAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166689,"kind":"person","name":"Naini Nader J","position":6,"cik":"0001344203","reported_name":"Naini Nader J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166690,"kind":"person","name":"Every Nathan R","position":7,"cik":"0001531105","reported_name":"Every Nathan R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37276,"kind":"person","name":"Heron Patrick J","position":8,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred Stock","published_at":"2017-01-31T16:20:33.000Z","date":"2017-01-31","kind":"exercise","acquired":false,"shares":733740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations.  The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations.  The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations.  The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners.  Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners.  Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":733740},"source":{"system":"sec-edgar","filing":"0001012975-17-000071","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1018534/000101297517000071/edgar.xml","form_type":"4"}},{"id":4475843,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":1,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":2,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":3,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":4,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166688,"kind":"person","name":"FRAZIER ALAN D","position":5,"cik":"0001018534","reported_name":"FRAZIER ALAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166689,"kind":"person","name":"Naini Nader J","position":6,"cik":"0001344203","reported_name":"Naini Nader J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166690,"kind":"person","name":"Every Nathan R","position":7,"cik":"0001531105","reported_name":"Every Nathan R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37276,"kind":"person","name":"Heron Patrick J","position":8,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C-1 Preferred Stock","published_at":"2017-01-31T16:20:33.000Z","date":"2017-01-31","kind":"exercise","acquired":false,"shares":195751,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series C-1 Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations.  The Series C-1 Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series C-1 Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations.  The Series C-1 Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series C-1 Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations.  The Series C-1 Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners.  Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners.  Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":195751},"source":{"system":"sec-edgar","filing":"0001012975-17-000071","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1018534/000101297517000071/edgar.xml","form_type":"4"}},{"id":4475842,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":1,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":2,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":3,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":4,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166688,"kind":"person","name":"FRAZIER ALAN D","position":5,"cik":"0001018534","reported_name":"FRAZIER ALAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166689,"kind":"person","name":"Naini Nader J","position":6,"cik":"0001344203","reported_name":"Naini Nader J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166690,"kind":"person","name":"Every Nathan R","position":7,"cik":"0001531105","reported_name":"Every Nathan R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37276,"kind":"person","name":"Heron Patrick J","position":8,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2017-01-31T16:20:33.000Z","date":"2017-01-31","kind":"exercise","acquired":false,"shares":604055,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series C Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations.  The Series C Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series C Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations.  The Series C Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series C Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations.  The Series C Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners.  Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners.  Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":604055},"source":{"system":"sec-edgar","filing":"0001012975-17-000071","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1018534/000101297517000071/edgar.xml","form_type":"4"}},{"id":4475841,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":1,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":2,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":3,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":4,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166688,"kind":"person","name":"FRAZIER ALAN D","position":5,"cik":"0001018534","reported_name":"FRAZIER ALAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166689,"kind":"person","name":"Naini Nader J","position":6,"cik":"0001344203","reported_name":"Naini Nader J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166690,"kind":"person","name":"Every Nathan R","position":7,"cik":"0001531105","reported_name":"Every Nathan R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37276,"kind":"person","name":"Heron Patrick J","position":8,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2017-01-31T16:20:33.000Z","date":"2017-01-31","kind":"exercise","acquired":false,"shares":1428571,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series B Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations.  The Series B Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series B Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations.  The Series B Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series B Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations.  The Series B Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners.  Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners.  Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1428571},"source":{"system":"sec-edgar","filing":"0001012975-17-000071","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1018534/000101297517000071/edgar.xml","form_type":"4"}},{"id":4475840,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":1,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":2,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":3,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":4,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166688,"kind":"person","name":"FRAZIER ALAN D","position":5,"cik":"0001018534","reported_name":"FRAZIER ALAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166689,"kind":"person","name":"Naini Nader J","position":6,"cik":"0001344203","reported_name":"Naini Nader J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166690,"kind":"person","name":"Every Nathan R","position":7,"cik":"0001531105","reported_name":"Every Nathan R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37276,"kind":"person","name":"Heron Patrick J","position":8,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-31T16:20:33.000Z","date":"2017-01-31","kind":"purchase","acquired":true,"shares":88709,"price":15,"value":1330635.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners.  Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners.  Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any."}],"balance_after":88709,"source":{"system":"sec-edgar","filing":"0001012975-17-000071","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1018534/000101297517000071/edgar.xml","form_type":"4"}},{"id":4475839,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":1,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":2,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":3,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":4,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166688,"kind":"person","name":"FRAZIER ALAN D","position":5,"cik":"0001018534","reported_name":"FRAZIER ALAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166689,"kind":"person","name":"Naini Nader J","position":6,"cik":"0001344203","reported_name":"Naini Nader J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166690,"kind":"person","name":"Every Nathan R","position":7,"cik":"0001531105","reported_name":"Every Nathan R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37276,"kind":"person","name":"Heron Patrick J","position":8,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-31T16:20:33.000Z","date":"2017-01-31","kind":"purchase","acquired":true,"shares":311291,"price":15,"value":4669365.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners.  Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners.  Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any."}],"balance_after":311291,"source":{"system":"sec-edgar","filing":"0001012975-17-000071","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1018534/000101297517000071/edgar.xml","form_type":"4"}},{"id":4475838,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":1,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":2,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":3,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":4,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166688,"kind":"person","name":"FRAZIER ALAN D","position":5,"cik":"0001018534","reported_name":"FRAZIER ALAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166689,"kind":"person","name":"Naini Nader J","position":6,"cik":"0001344203","reported_name":"Naini Nader J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166690,"kind":"person","name":"Every Nathan R","position":7,"cik":"0001531105","reported_name":"Every Nathan R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37276,"kind":"person","name":"Heron Patrick J","position":8,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-31T16:20:33.000Z","date":"2017-01-31","kind":"exercise","acquired":true,"shares":209095,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners.  Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations.  The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Represents shares held by Frazier Healthcare VII-A, L.P., an affiliate of Frazier Healthcare Partners.  Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any."}],"balance_after":209095,"source":{"system":"sec-edgar","filing":"0001012975-17-000071","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1018534/000101297517000071/edgar.xml","form_type":"4"}},{"id":4475837,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":1,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":2,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":3,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":4,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166688,"kind":"person","name":"FRAZIER ALAN D","position":5,"cik":"0001018534","reported_name":"FRAZIER ALAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166689,"kind":"person","name":"Naini Nader J","position":6,"cik":"0001344203","reported_name":"Naini Nader J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166690,"kind":"person","name":"Every Nathan R","position":7,"cik":"0001531105","reported_name":"Every Nathan R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37276,"kind":"person","name":"Heron Patrick J","position":8,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-31T16:20:33.000Z","date":"2017-01-31","kind":"exercise","acquired":true,"shares":733740,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners.  Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Series D Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations.  The Series D Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Represents shares held by Frazier Healthcare VII, L.P., an affiliate of Frazier Healthcare Partners.  Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any."}],"balance_after":733740,"source":{"system":"sec-edgar","filing":"0001012975-17-000071","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1018534/000101297517000071/edgar.xml","form_type":"4"}},{"id":4475836,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":1,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":2,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":3,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":4,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166688,"kind":"person","name":"FRAZIER ALAN D","position":5,"cik":"0001018534","reported_name":"FRAZIER ALAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166689,"kind":"person","name":"Naini Nader J","position":6,"cik":"0001344203","reported_name":"Naini Nader J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166690,"kind":"person","name":"Every Nathan R","position":7,"cik":"0001531105","reported_name":"Every Nathan R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37276,"kind":"person","name":"Heron Patrick J","position":8,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-31T16:20:33.000Z","date":"2017-01-31","kind":"exercise","acquired":true,"shares":195751,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners.  Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series C-1 Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations.  The Series C-1 Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners.  Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any."}],"balance_after":195751,"source":{"system":"sec-edgar","filing":"0001012975-17-000071","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1018534/000101297517000071/edgar.xml","form_type":"4"}},{"id":4475835,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":1,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":2,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":3,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":4,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166688,"kind":"person","name":"FRAZIER ALAN D","position":5,"cik":"0001018534","reported_name":"FRAZIER ALAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166689,"kind":"person","name":"Naini Nader J","position":6,"cik":"0001344203","reported_name":"Naini Nader J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166690,"kind":"person","name":"Every Nathan R","position":7,"cik":"0001531105","reported_name":"Every Nathan R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37276,"kind":"person","name":"Heron Patrick J","position":8,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-31T16:20:33.000Z","date":"2017-01-31","kind":"exercise","acquired":true,"shares":604055,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners.  Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series C Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations.  The Series C Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners.  Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any."}],"balance_after":604055,"source":{"system":"sec-edgar","filing":"0001012975-17-000071","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1018534/000101297517000071/edgar.xml","form_type":"4"}},{"id":4475834,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":137192,"kind":"organization","name":"Frazier Healthcare VII, L.P.","position":1,"cik":"0001553071","reported_name":"Frazier Healthcare VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137193,"kind":"organization","name":"Frazier Healthcare VII-A, L.P.","position":2,"cik":"0001575192","reported_name":"Frazier Healthcare VII-A, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137191,"kind":"organization","name":"FHM VII, L.P.","position":3,"cik":"0001654632","reported_name":"FHM VII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137190,"kind":"organization","name":"FHM VII, L.L.C.","position":4,"cik":"0001654631","reported_name":"FHM VII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166688,"kind":"person","name":"FRAZIER ALAN D","position":5,"cik":"0001018534","reported_name":"FRAZIER ALAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166689,"kind":"person","name":"Naini Nader J","position":6,"cik":"0001344203","reported_name":"Naini Nader J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166690,"kind":"person","name":"Every Nathan R","position":7,"cik":"0001531105","reported_name":"Every Nathan R","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":37276,"kind":"person","name":"Heron Patrick J","position":8,"cik":"0001365617","reported_name":"Heron Patrick J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-31T16:20:33.000Z","date":"2017-01-31","kind":"exercise","acquired":true,"shares":1428571,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners.  Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series B Preferred Stock converted into Common Stock on a 1-to-1 basis immediately prior to the consummation of the Issuer's initial public offering without payment of considerations.  The Series B Preferred stock were convertible automatically immediately prior to the consummation of the Issuer's initial public offering, and the shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners.  Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any."}],"balance_after":1428571,"source":{"system":"sec-edgar","filing":"0001012975-17-000071","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1018534/000101297517000071/edgar.xml","form_type":"4"}}]}